Silvercrest Asset Management’s ClearPoint Neuro CLPT Stock Holding History

Silvercrest Asset Management’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$325K	Hold	35,700	–	–	﹤0.01%	755
2025 Q4	$488K	Hold	35,700	–	–	﹤0.01%	718
2025 Q3	$778K	Hold	35,700	–	–	0.01%	644
2025 Q2	$426K	Hold	35,700	–	–	﹤0.01%	728
2025 Q1	$424K	Hold	35,700	–	–	﹤0.01%	728
2024 Q4	$549K	Hold	35,700	–	–	﹤0.01%	679
2024 Q3	$400K	Hold	35,700	–	–	﹤0.01%	679
2024 Q2	$192K	Hold	35,700	–	–	﹤0.01%	873
2024 Q1	$243K	Hold	35,700	–	–	﹤0.01%	827
2023 Q4	$242K	Hold	35,700	–	–	﹤0.01%	772
2023 Q3	$179K	Hold	35,700	–	–	﹤0.01%	802
2023 Q2	$258K	Hold	35,700	–	–	﹤0.01%	767
2023 Q1	$301K	Hold	35,700	–	–	﹤0.01%	719
2022 Q4	$302K	Hold	35,700	–	–	﹤0.01%	709
2022 Q3	$370K	Hold	35,700	–	–	﹤0.01%	678
2022 Q2	$466K	Buy	35,700 +6,500	+22%	+$66.4K	﹤0.01%	649
2022 Q1	$304K	Buy	29,200 +4,000	+16%	+$36.4K	﹤0.01%	760
2021 Q4	$283K	Hold	25,200	–	–	﹤0.01%	755
2021 Q3	$447K	Buy	25,200 +1,500	+6%	+$28.1K	﹤0.01%	698
2021 Q2	$452K	Hold	23,700	–	–	﹤0.01%	690
2021 Q1	$501K	Hold	23,700	–	–	﹤0.01%	667
2020 Q4	$377K	Hold	23,700	–	–	﹤0.01%	678
2020 Q3	$129K	Hold	23,700	–	–	﹤0.01%	728
2020 Q2	$84K	Hold	23,700	–	–	﹤0.01%	719
2020 Q1	$85K	Buy	+23,700	New	+$116K	﹤0.01%	679

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Silvercrest Asset Management's CLPT Position: Q1 2026 in Review

Silvercrest Asset Management held its ClearPoint Neuro (CLPT) position steady in Q1 2026 at 35,700 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #755.

Silvercrest Asset Management first reported a position in CLPT in Q1 2020 and has held it in 25 quarters since. The position peaked at $778K in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

Silvercrest Asset Management held 35,700 shares of ClearPoint Neuro worth $325K as of Q1 2026.
Silvercrest Asset Management left its ClearPoint Neuro share count unchanged in Q1 2026.
ClearPoint Neuro made up ﹤0.01% of Silvercrest Asset Management's portfolio in Q1 2026, its #755 holding.
Silvercrest Asset Management first reported a position in ClearPoint Neuro in Q1 2020 and has held it in 25 quarters since.
Silvercrest Asset Management's ClearPoint Neuro position peaked at $778K in Q3 2025.
118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Silvercrest Asset Management's 13F filing for Q1 2026, filed 15 May 2026.